Medicine Production News

News

Agilent, triple quadrupole GC/ | Agilent Technologies replaces signal-to-noise spec for triple
www.pharmaasia.com | Feb 16, 2012
Agilent Technologies announced that it is replacing the signal-to-noise specification with a instrument detection limit specification for its 7000B triple quadrupole gas chromatography/mass spectrometry system.

Lundbeck outstrips rivals with cost cuts - FT.com
www.ft.com | Jan 15, 2012
Lundbeck, the Danish drug maker, has cut its manufacturing costs by a quarter during the past five years, in a sign of increasing efforts by the pharmaceutical industry to boost efficiency as pressure rises on sales and profits. The company

Pharma Facilities | Groundbreakers: Tomorrow's Drug Manufacturing Facilities | Pharmaceutical
www.pharmamanufacturing.com | Jan 11, 2012
Modular construction and disposable process equipment are maximizing agility and minimizing risk.

Regulatory Compliance with One Eye on Cost - Pharmaceutical Technology
pharmtech.findpharma.com | Jan 10, 2012
A new book attempts to reduce the confusion and costs associated with regulatory compliance.

FDA Awards NIPTE Multimillion-Dollar Research Grant - - BioPharm International
biopharminternational.findpharma.com | Jan 8, 2012
Last week, FDA awarded a grant to the National Institute for Pharmaceutical Technology and Education (NIPTE) to improve drug development and manufacturing. The grant could be worth as much as $35 million over the next five years. Using the grant, NIPTE will conduct research in various areas,

Price Control of Medicines are detrimental for India’s Healthcare Growth Story & DrivesKewal Handa
www.prlog.org | Jan 6, 2012
Price Control of Medicines are detrimental for India’s Healthcare Growth Story & DrivesKewal Handa. Health Insurance & Availability should be the focus & not the Govt’s Draft Policy. Canada & Philippines growth is due to non-Price Control. - PR11765097

amednews: Interest building for drug shortage solution :: Dec. 12, 2011 ... American Medical News
www.ama-assn.org | Dec 12, 2011
Government officials point fingers at drugmakers, but some market observers say federal price controls may be a big factor.

FDA Adapting To Expansion Of Generic Drugs - Seeking Alpha
seekingalpha.com | Nov 21, 2011
< strong > By < a href="http://www.morningstar.com/" > Morningstar < /a > : < /strong > < p > The global expansion of the generic drug industry and the flood of applications for drugs losing patent protection have led to a backlog of drug approvals for the resource-constrained Food and Drug

LEO Pharma Selects Freeslate Core Module 3 for Sample Preparation of Viscous Drug Formulation
www.prweb.com | Nov 8, 2011
Freeslate continues to expand its installed base in Europe with Core Module 3 installation in Denmark

GP Pharm Obtains Approval for GCC Countries - Pharmaceutical Technology
www.pharmaceutical-technology.com | Aug 30, 2011
Home Products & Services Contract Manufacturing GP Pharm Press Release Company Details White Papers Press Releases Regional Offices Contact Company GP Pharm Obtains Approval for GCC Countries Email Article Print 30 August 2011 Last January, GCC-DR (Gulf Central Committee for Drug Registration)